Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
It is interesting to see these new oral medicines enter the market.
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
A clinical trial was conducted to evaluate the impact of Ginkgo biloba on cognitive function and depressive symptoms among 81 inpatients undergoing bilateral electroconvulsive therapy (ECT) for the treatment of major depressive disorder
THERAPEUTIC TARGETING OF miRNAs INVOLVED IN THE IGF-1 SIGNALING PATHWAY miRNAs have the profound potential as therapeutic agents due to their unique properties
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
